Cartesian Therapeutics, Inc. (RNAC) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 122.04M | 129.28M | 147.26M | 163.4M | 185.12M | 216.63M | 229.14M | 124.78M | 111.11M | 90.73M | 89.87M | 122.72M |
| Cash & Short-Term Investments | 118.64M | 125.14M | 143.38M | 160.32M | 180.43M | 212.61M | 219.2M | 87.23M | 103.42M | 76.91M | 79.6M | 112.03M |
| Cash Only | 118.64M | 125.14M | 143.38M | 160.32M | 180.43M | 212.61M | 219.2M | 87.23M | 103.42M | 76.91M | 79.6M | 112.03M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 261K | 1.11M | 722K | 354K | 1.76M | 872K | 5.81M | 35.51M | 4.38M | 8.85M | 6.77M | 6.44M |
| Days Sales Outstanding | 793.85 | 89.23 | 109.5 | 323.54 | 107.88 | -404.91 | 4.91K | 54.26 | 103.05 | 86.95 | 92.78 | 131.08 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 3.14M | 3.02M | 0 | 2.72M | 2.92M | 3.14M | 4.13M | 2.04M | 3.31M | 4.97M | 3.49M | 4.26M |
| Total Non-Current Assets | 166.35M | 167.13M | 225.41M | 225.5M | 224.01M | 218.4M | 226.18M | 222.96M | 214.1M | 214.32M | 16.16M | 16.78M |
| Property, Plant & Equipment | 17M | 17.79M | 17.37M | 17.45M | 15.53M | 15.45M | 23.75M | 20.52M | 11.96M | 12.18M | 12.76M | 13.37M |
| Fixed Asset Turnover | 0.00x | 0.05x | 0.03x | 0.02x | 0.07x | -0.04x | 0.02x | 2.06x | 0.48x | 0.66x | 0.50x | 0.38x |
| Goodwill | 48.16M | 48.16M | 48.16M | 48.16M | 48.16M | 48.16M | 48.16M | 48.16M | 48.16M | 48.16M | 0 | 0 |
| Intangible Assets | 93.9M | 93.9M | 150.6M | 150.6M | 150.6M | 150.6M | 150.6M | 150.6M | 150.6M | 150.6M | 0 | 0 |
| Long-Term Investments | 1.74M | 1.74M | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 2M |
| Other Non-Current Assets | 5.55M | 5.55M | 7.29M | 7.29M | 7.72M | 2.19M | 1.67M | 1.67M | 1.38M | 1.38M | 1.41M | 1.41M |
| Total Assets | 288.39M | 296.41M | 372.68M | 388.89M | 409.13M | 435.02M | 455.32M | 347.74M | 325.21M | 305.05M | 106.03M | 139.51M |
| Asset Turnover | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | -0.00x | 0.00x | 0.10x | 0.02x | 0.04x | 0.05x | 0.04x |
| Asset Growth % | -29.51% | -31.86% | -18.15% | 11.84% | 25.81% | 42.61% | 329.41% | 149.26% | 108.88% | 83.89% | -40.52% | -25.82% |
| Total Current Liabilities | 15.95M | 14.94M | 13.8M | 12.26M | 15M | 22.98M | 21.41M | 26.11M | 36.65M | 68.21M | 19.94M | 29.37M |
| Accounts Payable | 1.6M | 1.29M | 2.23M | 454K | 2.1M | 288K | 517K | 2.86M | 2.52M | 3.15M | 375K | 267K |
| Days Payables Outstanding | - | - | 9.63 | - | - | - | - | - | - | - | 2.27 | 3.4 |
| Short-Term Debt | 4.19M | 4.15M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10.23M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 412K | 2.31M | 4.14M | 4.23M |
| Other Current Liabilities | 10.16M | 9.5M | 107K | 0 | 0 | 7.76M | 8.76M | 10.12M | 22.57M | 45.85M | 0 | 0 |
| Current Ratio | 7.65x | 8.65x | 10.67x | 13.33x | 12.34x | 9.43x | 10.70x | 4.78x | 3.03x | 1.33x | 4.51x | 4.18x |
| Quick Ratio | 7.65x | 8.65x | 10.67x | 13.33x | 12.34x | 9.43x | 10.70x | 4.78x | 3.03x | 1.33x | 4.51x | 4.18x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 420.56M | 407.71M | 394.72M | 379.16M | 415.92M | 418.85M | 433.16M | 423.08M | 405.35M | 677.02M | 25.77M | 44.69M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13.79M |
| Capital Lease Obligations | 7.67M | 8.53M | 8.73M | 9.56M | 10.36M | 11.13M | 11.88M | 12.34M | 8.23M | 8.79M | 8.69M | 9.16M |
| Deferred Tax Liabilities | 6.95M | 6.95M | 0 | 16.14M | 0 | 0 | 15.85M | 15.85M | 15.85M | 0 | 0 | 0 |
| Other Non-Current Liabilities | 405.95M | 392.24M | 385.99M | 353.46M | 405.56M | 407.72M | 405.43M | 394.88M | 381.27M | 664.7M | 13.09M | 16.88M |
| Total Liabilities | 436.51M | 422.65M | 408.52M | 391.42M | 430.92M | 441.82M | 454.56M | 449.2M | 442.01M | 745.23M | 45.7M | 74.06M |
| Total Debt | 11.86M | 12.68M | 12.6M | 13.35M | 14.07M | 13.98M | 14.65M | 14.87M | 10.46M | 10.96M | 10.48M | 34.91M |
| Net Debt | -106.79M | -112.46M | -130.78M | -146.97M | -166.37M | -198.63M | -204.55M | -72.36M | -92.96M | -65.96M | -69.12M | -77.11M |
| Debt / Equity | - | - | - | - | - | - | 19.48x | - | - | - | 0.17x | 0.53x |
| Debt / EBITDA | - | - | - | - | - | - | - | 1.07x | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | -5.19x | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | -10.26x | -24.78x |
| Total Equity | -148.12M | -126.24M | -35.84M | -2.53M | -21.79M | -6.8M | 752K | -101.46M | -116.8M | -440.18M | 60.33M | 65.45M |
| Equity Growth % | -579.78% | -1755.92% | -4866.49% | 97.51% | 81.34% | 98.45% | -98.75% | -255.02% | -256.61% | -569.14% | -28.95% | -26.96% |
| Book Value per Share | -5.52 | -4.86 | -1.38 | -0.10 | -0.84 | -0.26 | 0.04 | -5.70 | -21.57 | -85.14 | 11.69 | 12.80 |
| Total Shareholders' Equity | -148.12M | -126.24M | -35.84M | -2.53M | -21.79M | -6.8M | 752K | -101.46M | -116.8M | -440.18M | 60.33M | 65.45M |
| Common Stock | 3K | 3K | 3K | 3K | 3K | 3K | 2K | 2K | 1K | 1K | 15K | 15K |
| Retained Earnings | -861.55M | -822.37M | -729.8M | -693.89M | -709.78M | -692.07M | -681.82M | -657.63M | -671.47M | -614.65M | -436.99M | -427.99M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -4.58M | -4.58M | -4.59M | -4.58M | -4.59M | -4.62M | -4.61M | -4.59M | -4.61M | -4.6M | -4.62M | -4.6M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |